Bluejay Diagnostics, Inc.

NASDAQ (USD): Bluejay Diagnostics, Inc. (BJDX)

Last Price

3.80

Today's Change

+0.17 (4.68%)

Day's Change

3.63 - 3.95

Trading Volume

13,897

Profile
BJDX

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Indranil Dey Mr. Indranil Dey

Full Time Employees:  10 10

IPO Date:  2021-11-10 2021-11-10

CIK:  0001704287 0001704287

ISIN:  US0956333019 US0956333019

CUSIP:  095633103 095633103

Beta:  0.73 0.73

Last Dividend:  0.00 0.00

Dcf Diff:  -8.93 -8.93

Dcf:  13.54 13.54

Description

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Address

360 Massachusetts Avenue,
Acton, MA 01720, US

844 327 7078

http://www.bluejaydx.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment